SCHEMBL11052697

SCHEMBL11052697

Cc1cc(C(c2cc(C)c(O)c(C)c2)C(F)(F)F)cc(C)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
PTGS1 P23219 8/20 0.38
PTGS2 P35354 8/20 0.38
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 1/20 0.35
ALOX5 P09917 6/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ACHE P22303 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22337425 0.92 CA2 (0.39) CA1CA2ESR1ESR2PTGS1
SCHEMBL24190794 0.86 GAA (0.50) CA1CA2ESR1ESR2PTGS1
SCHEMBL30429057 0.86 GAA (0.50) CA1CA2ESR1ESR2PTGS1
SCHEMBL11433564 0.84 CA1 (0.44) CA1CA2ESR1ESR2PTGS1
SCHEMBL24332735 0.83 ESR1 (0.41) ESR1ESR2
SCHEMBL22326117 0.79 ALDH1A1 (0.44) ESR1ESR2ALDH1A1GAAMAPT
SCHEMBL27272407 0.79 GLA (0.37) ESR1ESR2CYP1A2CYP2C9MAPT
SCHEMBL24191114 0.78 GPR35 (0.56) CA1CA2PTGS2CYP1A2CYP2C9
SCHEMBL30429503 0.78 GPR35 (0.56) CA1CA2PTGS2CYP1A2CYP2C9
SCHEMBL11050693 0.76 ESR1 (0.50) ESR1ESR2PTGS1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4365098-A Fluorinated diphenols and method for their preparation GENERAL ELECTRIC COMPANY (US) 1982-12-21 US claimed
US-12435185-B2 Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane CENTRAL GLASS COMPANY, LIMITED (JP) 2025-10-07 US disclosed
US-20220106444-A1 Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane CENTRAL GLASS COMPANY, LIMITED (JP) 2022-04-07 US disclosed
WO-2020162408-A1 METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE セントラル硝子株式会社 2020-08-13 WO disclosed
US-4467121-A Fluorinated diphenols and method for their preparation GENERAL ELECTRIC COMPANY (US) 1984-08-21 US disclosed
US-4379910-A Flame retardant aromatic polycarbonate compositions made from fluorinated diphenols GENERAL ELECTRIC CO. (US) 1983-04-12 US disclosed
EP-0067853-A4 FLAME RETARDANT AROMATIC POLYCARBONATES MADE FROM FLUORINATED DIPHENOLS. GEN ELECTRIC (US) 1983-04-06 EP disclosed
EP-0067853-A1 FLAME RETARDANT AROMATIC POLYCARBONATES MADE FROM FLUORINATED DIPHENOLS. GEN ELECTRIC (US) 1982-12-29 EP disclosed
WO-1982002402-A1 FLAME RETARDANT AROMATIC POLYCARBONATE COMPOSITIONS MADE FROM FLUORINATED DIPHENOLS GEN ELECTRIC (US) 1982-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106444-A1 Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane NAF1, FXR1, AFF1 CA1 337/4885CA2 424/4885ESR1 4737/4885
US-12435185-B2 Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane NAF1, FXR1, AFF1 CA1 337/4885CA2 424/4885ESR1 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.